Amgen paying $71M in off-label drug marketing case - Washington Times

Amgen paying $71M in off-label drug marketing case - Washington Times | marketing - Google News | August 18, 2015 at 04:05PM

Seeking Alpha

Amgen paying $71M in off-label drug marketing case Washington Times Less than three years ago, Amgen agreed to pay $762 million to settle a federal government inquiry into “off-label” marketing of the drugs and plead guilty to one criminal charge. Tuesday's settlement resolves state-level investigations into the same ... UPDATE 1-Amgen pays $71 mln to settle Enbrel, Aranesp marketing caseReuters Press Release: Amgen to Pay $71 Million for Improper Drug Marketing, AG Cooper ...Nasdaq $71 million settlement with drug company for 'off-label' marketing announcedTribune-Review all 71 news articles »

August 18, 2015 at 04:05PM | marketing - Google News
Amgen paying $71M in off-label drug marketing case - Washington Times
marketing - Google News